Current valuations are high, but future expectations are higher for Canada’s 28 public cannabis companies.

The media and events company is preparing for a public investment round. Alan Brochstein looks at the financials.

This is the third big marijuana stocks rally since 2013. Here are a couple lessons I learned from the first two.

The extraction process is fueling the boom in vaping, edibles, and concentrates. Who’s profiting from the trend?

Investment columnist Alan Brochstein examines the warning signs that investors might have heeded.

Both companies missed analysts’ revenue predictions, but investors didn’t seem to care.

Revenue generation isn’t always rewarded by the stock market. Here’s how to read revenue figures, and why you should dive deeper before investing.

Canadian Bioceutical, iAnthus Capital, and Liberty Health Sciences are moving capital south of the border.

Use the loonie to invest overseas: Canadian companies are involved in cannabis ventures on five continents.

Are those ’employees’ just models? Does the phone go straight to voicemail? Look for these and other red flags.